Zydus Pharmaceuticals (USA) Inc
4
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-03-18 to 2026-08-12
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-08-12 | FDA Drug | FDA Recall: Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesci | Zydus Pharmaceuticals (USA) Inc | Class II | N/A |
| 2026-05-27 | FDA Drug | FDA Recall: Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifescienc | Zydus Pharmaceuticals (USA) Inc | Class II | N/A |
| 2026-05-27 | FDA Drug | FDA Recall: Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifescienc | Zydus Pharmaceuticals (USA) Inc | Class II | N/A |
| 2026-03-18 | FDA Drug | FDA Recall: Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthc | Zydus Pharmaceuticals (USA) Inc | Class II | N/A |